A field guide to biology & AIInspired by the book

A COMPANY BUILT AROUND THE QUESTION

Understand. Investigate.
Create what comes next.

Unfinished Species is a biology and AI product from Maha Strategies. The proposed business combines evidence-led education, professional research tools, and a focused research studio.

The business, in three layers

01 / THE ATLAS

Knowledge people can use

Free exploration introduces the book and the science. Proposed memberships would support continuing editorial work.

02 / THE OBSERVATORY

Tools for research teams

Planned professional workflows would help teams compare evidence, organize sources, and follow relevant developments.

03 / THE STUDIO

Research with a measurable question

Proposed partner-led projects would test specific biological applications of AI, with commercial rights agreed in advance.

THE INTENDED OWNERSHIP MODEL

Invest in the company.

The founder’s intended model is equity ownership in the operating company. Future investment could support product development, scientific expertise, and contracted research under an agreed business plan.

Company ownership would be governed by the issuing entity and investment documents. Individual research projects would not automatically confer separate ownership or rights to their intellectual property.

There is no active securities offering here. The issuing entity, jurisdiction, valuation, terms, and fundraising process remain to be determined.

Start a company conversation →

WHAT EXISTS / WHAT COMES NEXT

Progress you can inspect.

✓

Version 1.0.0

Ten source-linked topics, the complete book, a source guide, saved collection, and the proposed research roadmap.

02

Validate the demand

Customer interviews, willingness-to-pay tests, and a defined professional workflow. No traction or revenue figures are claimed.

03

Prepare a research pilot

Secure a qualified partner, a costed proposal, and contractual rights before funding an experiment.

Inspect the proposed research program ↗

The investment concept is a company funding its own development and research program. This app does not accept investments, pool investor money, recommend securities, or promise returns.